Exicure (XCUR) Gains from Investment Securities (2017 - 2026)
Exicure's (XCUR) quarterly Gains from Investment Securities came in at $188000.0 in Q1 2026, up 38.24% YoY from $136000.0 in Q1 2025, and down 87.89% on a QoQ basis from $1.6 million in Q4 2025.
Exicure (XCUR) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Exicure (XCUR) has 7 years of Gains from Investment Securities data on file, last reported at $188000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 38.24% year-over-year to $188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 1477.94% YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
- Gains from Investment Securities eased to $188000.0 in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2025 to a low of $136000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 246,000.00 |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -56,000.00 |
| Dec 31, 2020 | -56,000.00 |
| Sep 30, 2020 | -186,000.00 |
| Sep 30, 2020 | -186,000.00 |
| Jun 30, 2020 | 189,000.00 |
| Jun 30, 2020 | 189,000.00 |